Influence of Sodium Bicarbonate on Time-to-exhaustion at Critical Power in Endurance Athletes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01621074 |
Recruitment Status :
Completed
First Posted : June 15, 2012
Last Update Posted : April 12, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Performance | Dietary Supplement: Sodium bicarbonate Dietary Supplement: Placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 12 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Study Start Date : | October 2011 |
Actual Primary Completion Date : | August 2012 |
Actual Study Completion Date : | January 2013 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Sodium bicarbonate |
Dietary Supplement: Sodium bicarbonate
Ergogenic effect |
Placebo Comparator: Placebo |
Dietary Supplement: Placebo
Placebo effect |
- Time-to-exhaustion [ Time Frame: 5 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion criteria: - male
- no cold or temperature at beginning or during the study
- between 18 and 45 years of age
- active in endurance sports (3 to 5 times per week a moderate to hart training)
- non-smoker
- no known cardiovascular or orthopedic problems
- no known limitations of kidney function
- no bearer of a cardiac pacemaker
- no medications with direct influence on the measurements. The whole intake of medicaments has to be declared in the health questionnaire by the participant.
- requirements of the health questionnaire fulfilled
Exclusion criteria: - female
- male and age under 18 or over 45 years
- cold or temperature at the beginning or during the study
- untrained (less than 3 moderate trainings per week)
- smoker
- cardiovascular or orthopedic problems
- limitations of the kidney function
- bearer of a cardiac pacemaker
- medication with direct influence on the measurements. The whole intake of medicaments has to be declared in the health questionnaire by the participant.
- requirements of the health questionnaire not fulfilled

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01621074
Switzerland | |
University Hospital Zurich, Division of Neurology | |
Zurich, ZH, Switzerland, 8091 |
Study Director: | Neurologie: Neurologische Forschung | University Hospital Zurich, Division of Neurology | |
Principal Investigator: | Marco Toigo, PhD | Swiss Federal Institute of Technology Zurich |
Responsible Party: | University of Zurich |
ClinicalTrials.gov Identifier: | NCT01621074 |
Other Study ID Numbers: |
nbc |
First Posted: | June 15, 2012 Key Record Dates |
Last Update Posted: | April 12, 2013 |
Last Verified: | April 2013 |